載入...
P08.55 δ-catenin modulates bevacizumab-induced glioma invasion
Introduction: Data showing that bevacizumab in combination with temozolomide and radiotherapy improved progression-free survival in patients with newly diagnosed glioblastoma have highlighted the potential of bevacizumab as a glioma therapy. However, while bevacizumab potently suppresses angiogenesi...
Na minha lista:
| 發表在: | Neuro Oncol |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5464067/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.244 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|